CAR-T

Delve into the world of CAR-T in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on CAR-T to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

FDA Approves Viatris's RYZUMVI for Presbyopia – Phentolamine Ophthalmic Solution 0.75% Adds Age‑Related Vision Indication to Existing Mydriasis Label
CompanyDrug

FDA Approves Viatris’s RYZUMVI for Presbyopia – Phentolamine Ophthalmic Solution 0.75% Adds Age‑Related Vision Indication to Existing Mydriasis Label

Viatris Inc. (NASDAQ: VTRS) announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults. RYZUMVI is already…

GSK Reports First Global Data for B7‑H3 ADC Risvutatug Rezetecan – 61% Confirmed ORR at 8 mg/kg in Relapsed ES‑SCLC Phase Ib

GSK Reports First Global Data for B7‑H3 ADC Risvutatug Rezetecan – 61% Confirmed ORR at 8 mg/kg in Relapsed ES‑SCLC Phase Ib

Qingfeng Pharmaceutical Signs Five‑Year Strategic Collaboration with China Association Against Epilepsy – Advancing Discipline Development, Talent Cultivation and Patient Assistance

Qingfeng Pharmaceutical Signs Five‑Year Strategic Collaboration with China Association Against Epilepsy – Advancing Discipline Development, Talent Cultivation and Patient Assistance

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Cygenta Partners with IZVARINO Pharma for Comprehensive CDMO Services
CompanyDeals

Cygenta Partners with IZVARINO Pharma for Comprehensive CDMO Services

CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2219 in China
CompanyDrug

CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2219 in China

CARsgen Therapeutics' Satricabtagene Autoleucel Shows Positive Results in Phase II Study
CompanyDrug

CARsgen Therapeutics’ Satricabtagene Autoleucel Shows Positive Results in Phase II Study

ImmunoTech Biopharm's CAR-T-19 Earns Breakthrough Therapy Designation for B-ALL Treatment
CompanyDrug

ImmunoTech Biopharm’s CAR-T-19 Earns Breakthrough Therapy Designation for B-ALL Treatment

Legend Biotech's Carvykti Demonstrates High MRD Negativity Rates in Phase III CARTITUDE-4 Trial
CompanyDrug

Legend Biotech’s Carvykti Demonstrates High MRD Negativity Rates in Phase III CARTITUDE-4 Trial

Immunofoco's IMC002 Earns FDA Fast-Track Designation for CLDN 18.2-Positive Gastric Cancer
CompanyDrug

Immunofoco’s IMC002 Earns FDA Fast-Track Designation for CLDN 18.2-Positive Gastric Cancer

Precision Biotech and T&L Biotechnology Form Partnership to Advance Cell and Gene Therapies
CompanyDeals

Precision Biotech and T&L Biotechnology Form Partnership to Advance Cell and Gene Therapies

Immunofoco's IMC002 CAR-T Therapy Receives FDA Fast Track Designation for Gastric Cancer
CompanyDrug

Immunofoco’s IMC002 CAR-T Therapy Receives FDA Fast Track Designation for Gastric Cancer

Show More